Terns Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Terns Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Terns Pharmaceuticals Inc
Rating: 1.86516675
Author: Trendlyne DVM scores

about

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chron...

37.19 2.74 (7.95%)

1899.46% Gain from 52W Low

3.9M

XNAS Volume

XNAS 14 Jan, 2026 4:03 PM (EST)

Not Eligible

Expensive Valuation

2.2 / 100

Technically Bullish

72.4 / 100

No estimates available

Terns Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Terns Pharma Inc Live Stock Price Today, Share Analysis and Chart

Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chron...

1899.46% Gain from 52W Low

SWOT Analysis

Terns Pharma Inc Live Price Chart